CClinicalTrials.gg
CompletedNCT07744451Updated Aug 4, 2026

Kinesiotaping Versus Physiotherapy for Post-Covid-19 Back Pain

An interventional study of Kinesiotaping and Conventional Physiotherapy in Post-COVID-19 Syndrome, Back Pain and Musculoskeletal Pain, sponsored by Medipol University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Medipol University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 6 months after the study started (first participant enrolled Jan 2021, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Objective:

This study aims to compare and evaluate the effectiveness of kinesiotaping and traditional physiotherapy methods, which are frequently used in the treatment of musculoskeletal diseases, on mid-back pain (MBP) developed after COVID-19.

Study Design and Methods:

Patients aged 18 or older who have been diagnosed with COVID-19, have completed their medical treatment, and whose isolation period has ended are included in the study. The patients' age, sex, and body mass index (BMI) are recorded.

The participants are assigned to receive one of two interventions. In the first group, kinesiotapes are applied and left on the patient's back for a total of 10 days. The second group is treated with traditional physiotherapy methods, specifically Vacuum Interferential Current Therapy and Hot Pack Therapy.

Clinical evaluations are performed using the Visual Analogue Scale (VAS), Pain Quality Assessment Scale, LANSS Neuropathic Pain Scale, and Nottingham Extended Activities of Daily Living Index. Measurements are taken at two time points: baseline (pre-treatment) and at the end of the 10th day (post-treatment).,

02

Conditions studied

  • Post-COVID-19 Syndrome
  • Back Pain
  • Musculoskeletal Pain
03

In context

Post-Acute COVID-19 Syndrome

520 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 186 are open to participants now.

This study's enrollment of 33 is below the median of 60 across 361 interventional studies indexed under Post-Acute COVID-19 Syndrome.

Browse Post-Acute COVID-19 Syndrome studies →

Lead sponsor

Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 18 years and older.
  • Patients experiencing mechanical mid-back pain (MBP) that developed after recovering from a confirmed COVID-19 infection.
  • Volunteering to participate in the study and providing written informed consent.

Exclusion criteria

Exclusion Criteria:

  • History of previous spinal surgery or spinal trauma.
  • Presence of structural spinal deformities (e.g., severe kyphosis or scoliosis).
  • Presence of radicular pain, neurological deficits, or suspected disc herniation.
  • Active infection, malignancy, or severe systemic inflammatory diseases.
  • Known skin allergy or dermatological conditions preventing the application of Kinesio Tape.
  • Pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Active comparator
    Physiotherapy Group

    Patients in this group received conventional physiotherapy, including 20 minutes of Hot Pack Therapy and 20 minutes of Vacuum Interferential Current Therapy (100 Hz). Daily sessions lasted 60 minutes and included home-based ROM and stretching exercises.

    Procedure: Conventional Physiotherapy

  • Experimental
    Kinesiotaping Group

    Patients in this group received Kinesio Tape (Kinesio® Tex Tape Gold) applied to the bilateral erector spinae muscles starting from the T12 vertebra level. The tape was renewed once every three days for a total treatment duration of 10 days.

    Device: Kinesiotaping

Interventions

  • DeviceKinesiotaping

    Application of 5x5 cm Kinesio Tape with a slight stretch of approximately 10 to 15% on the painful back area during trunk flexion and contralateral rotation.

  • ProcedureConventional Physiotherapy

    Application of hot packs and vacuum interferential current therapy using diagonally placed vacuum electrodes (Intelect Mobile Combo®, USA) to encompass the pain area.

06

What researchers measure

Primary outcomes

  1. Pain Intensity assessed by Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is used to evaluate the patient's mid-back pain intensity under three conditions: at rest, at night, and during activity/exercise. The scale is a 10 cm line where 0 represents "no pain" and 10 represents "the worst imaginable pain." Higher scores indicate greater pain severity.

    Time frame: Baseline (Pre-treatment) and Day 10 (Post-treatment)

07

Study locations

1 site
  • Istanbul Medipol University Pendik Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 24, 2020
  • Protocol and statistical analysis plan · Jul 28, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07744451
Lead sponsor
Medipol University
Responsible party
Çağlayan Aslanbaş (Asst. Prof. Dr., Medipol University) — Principal investigator
First posted
Aug 4, 2026
Start date
Jan 1, 2021
Primary completion
Apr 11, 2021
Completion
Apr 11, 2021
Last update
Aug 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion